SCHEMBL4935140

SCHEMBL4935140

CCCCC(=O)Nc1ccc(CC(N)C(=O)NO)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 10/20 0.55
HDAC3 O15379 8/20 0.55
HDAC6 Q9UBN7 8/20 0.55
HDAC1 Q13547 7/20 0.55
HDAC2 Q92769 6/20 0.55
HDAC4 P56524 5/20 0.55
HDAC7 Q8WUI4 5/20 0.55
HDAC10 Q969S8 5/20 0.55
HDAC11 Q96DB2 5/20 0.55
HDAC9 Q9UKV0 5/20 0.55
HDAC5 Q9UQL6 5/20 0.55
CA1 P00915 2/20 0.52
CA2 P00918 2/20 0.52
CA12 O43570 1/20 0.52
CA9 Q16790 1/20 0.52
CSK P41240 1/20 0.51
ENPP2 Q13822 1/20 0.49
DGAT2 Q96PD7 1/20 0.49
HPGD P15428 1/20 0.49
ALDH1A1 P00352 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4935136 1.00 HDAC8 (0.55) HDAC8HDAC3HDAC6HDAC1HDAC2
SCHEMBL4934979 0.82 CSK (0.60) HDAC8CA1CA2CA12CA9
SCHEMBL4934991 0.82 CSK (0.60) HDAC8CA1CA2CA12CA9
SCHEMBL21689987 0.82 ENPP2 (0.59) HDAC8HDAC3HDAC6HDAC1HDAC2
SCHEMBL5678587 0.78 MAPT (0.59) HDAC8HDAC3HDAC6HDAC1HDAC2
SCHEMBL4934030 0.78 CSK (0.56) HDAC8CSKHPGD
SCHEMBL4934022 0.78 CSK (0.56) HDAC8CSKHPGD
SCHEMBL27828203 0.78 ENPP2 (0.54) HDAC8HDAC3HDAC6HDAC1HDAC2
SCHEMBL4415174 0.77 ENPP2 (0.60) HDAC8HDAC3HDAC6HDAC1HDAC2
SCHEMBL4930575 0.77 CSK (0.55) HDAC8HDAC3HDAC6HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative KUREHA CORPORATION (JP) 2008-06-05 US disclosed
EP-1707560-A1 HYDROXAMIC ACID DERIVATIVE AND AGE GENERATION INHIBITOR CONTAINING THE DERIVATIVE Kureha Corporation (JP) 2006-10-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative HDAC5, HDAC1, HDAC9 HDAC8 4/4885HDAC3 17/4885HDAC6 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.